LAKSHMI SAVITALA-DAMERLA: Open Payments
NPI 1992860399 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$417 in 4 payments from 4 companies in 2025. Trend: 2023 $710 · 2024 $622 · 2025 $417
Speaker / faculty: $225Food & beverage: $192
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $225 |
| Incyte Corporation | 1 | $140 |
| JAZZ PHARMACEUTICALS INC. | 1 | $32 |
| ABBVIE INC. | 1 | $20 |
Products named: Fabhalta, Jakafi, RYLAZE, EPKINLY.
Industry payments across CA — which companies pay providers there.
